Identification of four new mutations in the cystic fibrosis transmembrane conductance regulator gene: I148T, L1077P, Y1092X, 2183AA→G
✍ Scribed by Dominique Bozon; Julian Zielenski; Frauke Rininsland; Lap-Chee Tsui
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 347 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
✦ Synopsis
sible for CF was cloned and the most prevalent mutation (AF508) identified Kerem et al., 1989) over 300 different mutations in the CF transmembrane conductance regulator (CFTR) gene have been reported to the Cystic Fibrosis Genetic Analysis Consortium (Tsui, 1992a,b). By analysing DNA changes in CFTR gene from CF chromosomes representing the Canadian population we identified four new mutations: I148T in exon 4; a complex frameshift mutation in exon 13; 2183AA-G; L1077P and Y1092X in exon 17b.
All mutations reported here were detected and characterized by direct sequencing of PCR-amplified DNA segments corresponding to exons, 4, 13, and 17b of CFTR gene. Primers and reaction conditions for PCR-amplification of the analyzed exons were reported before .
📜 SIMILAR VOLUMES
Six new mutations have been identified in the CFTR gene. These mutations, representing three different categories-missense (R3 lL, W1098R), nonsense ( E l 104X), and frameshift (441delA, 681delC, 1461ins4)-are located in exons 2 , 4 , 5 , 9 , and 17b of the gene and presumed to cause cystic fibrosis
The cystic fibrosis transmembrane conductance regulator (CFTR) gene encodes a cAMP-activated chloride channel, and in individuals with both alleles of the gene mutated, symptoms of CF disease are manifest. With more than 300 mutations so far described in the gene the profile of mutant alleles in a p
The mutation described here has been detected in the DNA of a female cystic fibrosis (CF) patient born in May 1963. CF has been diagnosed only at the age of 30 years and has been confirmed by three positive sweat tests. She does not require supplementation with pancreatic enzymes and her pulmonary f